ARCHIVES

FDA Committee to Discuss Policy On Combinations

This article is from The Cancer Letter archive.

Vol. 03 No. 01 | January 7, 1977

Download PDF Visit The Full Archive

Related Articles

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

ASCO Foundation Renamed

February 18, 2011

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

“National Clearinghouse” To Guide Selection, Testing, Evaluating Of Suspected Carcinogens

April 9, 1976

Rich Left AMC “For Personal Reasons”

April 21, 1989

CPRU Program Gets Basic Concept Approval

October 2, 1987